Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,799 | -6,481 | -3,335 | -14,658 | -8,845 |
| Depreciation Amortization | 168 | 55 | 64 | 480 | 381 |
| Accounts receivable | N/A | -564 | N/A | 2 | 29 |
| Accounts payable and accrued liabilities | 408 | 68 | 453 | 265 | 191 |
| Other Working Capital | -831 | -1,291 | 555 | 320 | 2 |
| Other Operating Activity | 1,054 | 1,694 | -736 | 3,036 | 406 |
| Operating Cash Flow | $-10,000 | $-6,519 | $-2,999 | $-10,556 | $-7,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | 58 | -28 | 159 | -103 |
| Purchase Sale Intangibles | -16 | -16 | N/A | -164 | -185 |
| Other Investing Activity | -59 | -140 | -38 | -502 | -185 |
| Investing Cash Flow | $-111 | $-82 | $-66 | $-343 | $-288 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -49 | N/A | N/A | -99 | 0 |
| Common Stock Issued | 9,499 | 9,503 | 4,292 | 13,156 | 13,156 |
| Financing Cash Flow | $9,449 | $9,503 | $4,292 | $13,057 | $13,156 |
| Beginning Cash Position | 8,501 | 8,501 | 8,501 | 6,342 | 6,342 |
| End Cash Position | 7,839 | 11,403 | 9,728 | 8,501 | 11,374 |
| Net Cash Flow | $-661 | $2,902 | $1,228 | $2,159 | $5,032 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,000 | -6,519 | -2,999 | -10,556 | -7,836 |
| Capital Expenditure | -51 | 58 | -28 | 159 | -103 |
| Free Cash Flow | -10,051 | -6,461 | -3,027 | -10,397 | -7,939 |